99 related articles for article (PubMed ID: 30149365)
1. The role of epidermal growth factor receptor (EGFR) common gene mutations in Iranian women with uterine fibroids.
Nikpey P; Nazari T; Khalili S; Ebrahimi A
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():103-107. PubMed ID: 30149365
[TBL] [Abstract][Full Text] [Related]
2. Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population.
Mostafavi SS; Ebrahimi A; Sadat SM; Davari Tanha F; Aghasadeghi MR; Bahramali G; Abbasi Ranjbar P; Sadeghifard V; Javadi F
J Obstet Gynaecol Res; 2016 Apr; 42(4):434-9. PubMed ID: 26785830
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for
Dzhemlikhanova LK; Efimova OA; Osinovskaya NS; Parfenyev SE; Niauri DA; Sultanov IY; Malysheva OV; Pendina AA; Shved NY; Ivashchenko TE; Yarmolinskaya MI; Kakhiani MI; Gorovaya EA; Tkachenko AN; Baranov VS
J Clin Pathol; 2017 Mar; 70(3):233-236. PubMed ID: 27491313
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.
Fischer C; Juhasz-Boess I; Lattrich C; Ortmann O; Treeck O
Gynecol Endocrinol; 2010 Jan; 26(1):4-9. PubMed ID: 19639498
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
[TBL] [Abstract][Full Text] [Related]
6. [MED12 gene mutations in women with uterine myoma].
Osinovskaya NS; Ivashchenko TE; Dolinskii AK; Sultanov IY; Ghimbovchi S; Hoffman E; Bezhenar VF; Baranov VS
Genetika; 2013 Dec; 49(12):1426-31. PubMed ID: 25438604
[TBL] [Abstract][Full Text] [Related]
7. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
8. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
[TBL] [Abstract][Full Text] [Related]
9. The -2549 insertion/deletion polymorphism of VEGF gene associated with uterine leiomyoma susceptibility in women from Southeastern Iran.
Keshavarzi F; Salimi S; Mohammadpour-Gharehbagh A; Teimoori B; Yazdi A; Farajian-Mashhadi F; Yaghmaei M; Mokhtari M
Ginekol Pol; 2017; 88(3):115-119. PubMed ID: 28397198
[TBL] [Abstract][Full Text] [Related]
10. Detection of EGFR gene polymorphisms in non-small cell lung cancer Egyptian patients: a case-control study.
El-Khawaga OY; Al-Azzawy MF; ElSaid AM; Refaat S; El-Dawa AN
Genes Environ; 2023 Nov; 45(1):32. PubMed ID: 38008767
[TBL] [Abstract][Full Text] [Related]
11. Analysis of TP53 gene in uterine myomas: No mutations but P72R polymorphism is associated with myoma development.
Altinkaya SO; Avcioglu SN; Sezer SD; Ceylaner S
J Obstet Gynaecol Res; 2019 Oct; 45(10):2088-2094. PubMed ID: 31357239
[TBL] [Abstract][Full Text] [Related]
12. Studies on leptin and leptin receptor gene expression in myometrium and uterine myomas of gnRH analogue-treated women.
Markowska A; Rucinski M; Drews K; Malendowicz LK
Eur J Gynaecol Oncol; 2006; 27(4):379-84. PubMed ID: 17009630
[TBL] [Abstract][Full Text] [Related]
13. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
15. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
17. The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.
Sadeghi S; Khorrami M; Amin-Beidokhti M; Abbasi M; Kamalian Z; Irani S; Omrani M; Azmoodeh O; Mirfakhraie R
Tumour Biol; 2016 Feb; 37(2):1567-71. PubMed ID: 26298726
[TBL] [Abstract][Full Text] [Related]
18. The progesterone receptor gene polymorphism, PROGINS, may be a factor related to the development of uterine fibroids.
Gomes MT; Castro Rde A; Villanova FE; da Silva ID; Baracat EC; de Lima GR; Girão MJ
Fertil Steril; 2007 May; 87(5):1116-21. PubMed ID: 17224149
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk.
Renner SP; Strick R; Fasching PA; Oeser S; Oppelt P; Mueller A; Beckmann MW; Strissel PL
Am J Obstet Gynecol; 2008 Dec; 199(6):648.e1-9. PubMed ID: 18691687
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
